(Q54631175)

1 June 2018

title

Piperacillin/tazobactam in complicated urinary tract infections. (English)

1 reference

1 June 2018

main subject

piperacillin/tazobactam

1 reference

P Nowé

1

1 reference

1 June 2018

publication date

1 July 1994

1 reference

1 June 2018

published in

Intensive Care Medicine

1 reference

1 June 2018

volume

20 Suppl 3

1 reference

1 June 2018

page(s)

S39-42

1 reference

1 June 2018

https://scigraph.springernature.com/pub.10.1007/bf01745250

exact match

0 references

cites work

Patterns and mechanisms of beta-lactam resistance among isolates of Escherichia coli from hospitals in the United States

1 reference

https://api.crossref.org/works/10.1007%2FBF01745250

Piperacillin Sodium: Antibacterial Spectrum, Pharmacokinetics, Clinical Efficacy, and Adverse Reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745250

Piperacillin: a review of clinical experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745250

Comparative evaluation of a new beta-lactamase inhibitor, YTR 830, combined with different beta-lactam antibiotics against bacteria harboring known beta-lactamases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745250

beta-Lactamases and beta-lactam resistance in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745250

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF01745250

Synergistic combinations of penicillins in the treatment of bacteriuria

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7962988

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Piperacillin, a new penicillin active against many bacteria resistant to other penicillins

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7962988

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830).

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/7962988

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/BF01745250

1 reference

1 June 2018

PubMed ID

7962988

1 reference

1 June 2018